The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous mitral valve annuloplasty.
Mitral regurgitation occurs when one of the four valves in the heart - the mitral valve - does not close properly, allowing blood to leak backwards. It may lead to shortness of breath and eventually heart failure (where the heart cannot pump enough blood to meet the body's needs). In this procedure, a catheter is inserted into a large vein in the groin or neck and passed through to the heart. A device is placed into a large vein that sits next to the mitral valve to constrict the valve, with the aim of making it close properly.
K35.8 Other specified therapeutic transluminal operations on valve of heart
Y02.2 Insertion of prosthesis into organ NOC
Y53.4 Approach to organ under fluoroscopic control
Z32.1 Mitral valve
U20.2 Transoesophageal echocardiography (if carried out)
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.